Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ALNYLAM PHARMACEUTICALS, INC. (ALNY) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ALNYLAM PHARMACEUTICALS, INC. (ALNY), most recent 12 months reported: revenue $4.8B, net income $807.99M, free cash flow $819.87M. Latest balance sheet on file: liquid cash $3.31B. From SEC filings. More on ALNYLAM PHARMACEUTICALS, INC.: Revenue · Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: Zoetis Inc. · BEONE MEDICINES LTD. · Organon & Co. · Elanco Animal Health Incorporated · Jazz Pharmaceuticals plc · Perrigo Company plc · BIOMARIN PHARMACEUTICAL INC · United Therapeutics Corporation

Stock screener

Watchlist